Works matching Drug prices

Results: 5000

Analysis of e-catalogue drug prices in the era of Universal Health Coverage in the Indonesian pharmaceutical industry.

Published in:

Pharmacia (0428-0296), 2022, v. 69, n. 2, p. 555, doi. 10.3897/pharmacia.69.e83068

By:

Satibi, Satibi;
P., Luthfi Kinanthi Kirana;
P., Mella Aziza;
Hutasoit, Monica;
Pribadi, Prasojo

Publication type:

Article

基于主要信息含量药品价格特征指标体系的构建.

Published in:

Journal of Pharmaceutical Practice & Service, 2018, v. 36, n. 5, p. 422, doi. 10.3969/j.issn.1006-0111.2018.05.008

By:

李建;
舒丽芯

Publication type:

Article

Is greater generic competition also linked to lower drug prices in South Korea?

Published in:

Health Economics Review, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13561-020-00289-6

By:

Son, Kyung-Bok

Publication type:

Article

Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.

Published in:

2015

By:

Junyong Wang;
Xia Liu;
Suzhen Wang;
Heli Chen;
Xun Wang;
Wei Zhou;
Li Wang;
Yanchen Zhu;
Xianping Zheng;
Mo Hao

Publication type:

Case Study

Drugs Prices and Systemic Violence: An Empirical Study.

Published in:

European Journal on Criminal Policy & Research, 2008, v. 14, n. 4, p. 391, doi. 10.1007/s10610-008-9080-9

By:

Sarrica, Fabrizio

Publication type:

Article

Variables affecting new drug prices in South Korea's pricing system.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1370915

By:

Dong Yun Lee;
Seong Ha Cho;
Da Hye Lee;
Su Jeong Kang;
Jong Hyuk Lee

Publication type:

Article

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1179253

By:

Narendrula, Aparna;
Lang, Jacob;
Mossialos, Elias

Publication type:

Article

Research on the sharing mechanism of drug price information in China-from the perspective of intergovernmental information sharing.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2018, v. 27, n. 8, p. 582, doi. 10.5246/jcps.2018.08.059

By:

Shuai Wang;
Ting Yin;
Ningtai Luo;
Xiaoping Liu;
Bin Jiang

Publication type:

Article

Impact of drug price regulation on patient access to medicines: A systematic review.

Published in:

Matrix Science Pharma, 2023, v. 7, n. 4, p. 112, doi. 10.4103/mtsp.mtsp_23_23

By:

Ashiwaju, Bankole;
Orikpete, Ochuko;
Alade, Elesho;
Raji, Ahmed;
Adesanya, Abel;
Nwankwo, Tochukwu

Publication type:

Article

The impact of patent expiry on drug prices: insights from the Dutch market.

Published in:

Journal of Market Access & Health Policy, 2021, v. 9, n. 1, p. 1, doi. 10.1080/20016689.2020.1849984

By:

van der Schans, Simon;
Vondeling, Gert T.;
Cao, Qi;
van der Pol, Simon;
Visser, Sipke;
Postma, Maarten J.;
Rozenbaum, Mark H.

Publication type:

Article

Why "American Patients First" is likely to raise drug prices outside of the United States.

Published in:

Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2019.1650596

By:

Dabbous, Monique;
Milea, Cyprien;
Simoens, Steven;
François, Clement;
Dussart, Claude;
Chachoua, Lylia;
Borissov, Borislav;
Toumi, Mondher

Publication type:

Article

President Trump's prescription to reduce drug prices: from the campaign trail to American Patients First.

Published in:

Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2019.1579597

By:

Dabbous, Monique;
François, Clément;
Chachoua, Lylia;
Toumi, Mondher

Publication type:

Article

Can Drug Price Controls Help Patients Get a Better Deal? A SWOT Analysis.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, n. 6, p. 222, doi. 10.47836/mjmhs.19.6.30

By:

Wahab, Siti Norida;
Sahak, Muhammad Yazid

Publication type:

Article

Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada.

Published in:

ClinicoEconomics & Outcomes Research, 2024, v. 16, p. 437, doi. 10.2147/CEOR.S462872

By:

Rawson, Nigel SB;
Stewart, David J

Publication type:

Article

Correlation of Anticancer Drug Prices with Outcomes of Overall Survival and Progression-Free Survival in Clinical Trials in Japan.

Published in:

Current Oncology, 2023, v. 30, n. 2, p. 1776, doi. 10.3390/curroncol30020137

By:

Okabe, Ayano;
Hayashi, Haruto;
Maeda, Hideki

Publication type:

Article

Why Lower Drug Prices Benefit Institutional Investors: an application of universal ownership theory.

Published in:

Corporate Governance: An International Review, 2007, v. 15, n. 3, p. 455, doi. 10.1111/j.1467-8683.2007.00578.x

By:

Lippman, Steve;
Rosan, Daniel E.;
Seitchik, Adam

Publication type:

Article

Generic entry and effect of market competition on outpatient pharmacy drug prices.

Published in:

Journal of Generic Medicines, 2024, v. 20, n. 2, p. 69, doi. 10.1177/17411343241248521

By:

Jamjoom, Mohammed;
Almutairi, Reem D;
Seoane-Vazquez, Enrique;
Brown, Lawrence M;
Burnham, Terence;
Rakovski, Cyril;
Rodriguez-Monguio, Rosa

Publication type:

Article

ID 169. The Impact of Rising Drug Prices in Egypt.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2020, v. 12, p. 909

By:

Abdeldaiem, Mahmoud Said Ibrahim;
Fathalla, Nour Allah Hassan;
El-Sayed, Nouran Ehab Hassan;
Hedaya, Heidy Yasser

Publication type:

Article

The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017.

Published in:

Journal of Evolutionary Economics, 2022, v. 32, n. 4, p. 1155, doi. 10.1007/s00191-022-00777-4

By:

Lichtenberg, Frank R.

Publication type:

Article

The Price Effect of Drug Price Ceilings: Intended and Unintended Consequences.

Published in:

Management Science, 2022, v. 68, n. 8, p. 5758, doi. 10.1287/mnsc.2021.4166

By:

Li, Jun;
Wu, Di

Publication type:

Article

Impact of Regulatory Policy Changes on Generic Drug Prices in the United States.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 2, p. 617, doi. 10.5530/ijper.57.2.76

By:

Singh, Rajender;
Singh, Swati;
Kumar, Anil;
Kulkarni, G. T.;
Thakkar, Arti R.

Publication type:

Article

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis.

Published in:

2021

By:

Wang, Ni;
Yang, Ying;
Xu, Luxinyi;
Mao, Zongfu;
Cui, Dan

Publication type:

journal article

The impact of early phase price agreements on prices of orphan drugs.

Published in:

2021

By:

Nuijten, Mark;
Van Wilder, Philippe

Publication type:

journal article

Monitoramento de políticas públicas em direitos fundamentais: a regulação de preços de medicamentos por meio da CMED.

Published in:

Revista Brasileira de Políticas Públicas, 2024, v. 14, n. 2, p. 228, doi. 10.5102/rbpp.v14i2.8874

By:

Villa Verde, Rômulo Goretti;
de Oliveira Rodrigues, Liziene;
Chein Feres, Marcos Vinicio

Publication type:

Article

The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.

Published in:

BMC Public Health, 2024, v. 24, p. 1, doi. 10.1186/s12889-024-18820-3

By:

Li, Bao-Xin;
Wang, Ya-Qun;
Yi, Yuan-Yuan;
Zhou, Na;
Lv, Zi-Xuan;
Ma, Rui;
Li, Xin;
Yuan, Ni

Publication type:

Article

Does drug price-regulation affect healthcare expenditures?

Published in:

2017

By:

Ben-Aharon, Omer;
Shavit, Oren;
Magnezi, Racheli

Publication type:

journal article

Drug Prices - How Much is too Much?

Published in:

Journal of Intellectual Property Rights, 2012, v. 17, n. 5, p. 497

By:

Nair, Manu S.

Publication type:

Article

New Evidence of the Impact of the National Drug Price Negotiation Policy on the Availability, Utilization, and Cost of Anticancer Medicines in China: An Interrupted Time Series Study.

Published in:

Risk Management & Healthcare Policy, 2024, v. 17, p. 2201, doi. 10.2147/RMHP.S473846

By:

Gao, Xingyuan;
Yu, Man;
Sun, Yuyang;
Zhang, Tiansi;
Li, Xin;
Zhang, Lingli;
Wang, Changqing

Publication type:

Article

Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML Experts.

Published in:

Current Medical Literature: Leukemia & Lymphoma, 2013, v. 21, n. 2, p. 64

By:

Mead, Adam

Publication type:

Article

WILL PRESCRIPTION DRUG PRICES EVER STOP RISING? A WORK AROUND TO AVOIDING THE DORMANT COMMERCE CLAUSE IN STATE REGULATION OF DRUG PRICES.

Published in:

University of Pennsylvania Journal of Constitutional Law, 2024, v. 26, n. 6, p. 1667, doi. 10.58112/jcl.26-6.6

By:

Nwakama, Chisom

Publication type:

Article

Price negotiation and pricing of anticancer drugs in China: An observational study.

Published in:

PLoS Medicine, 2024, v. 21, n. 1, p. 1, doi. 10.1371/journal.pmed.1004332

By:

Zhou, Jing;
Lan, Tianjiao;
Lu, Hao;
Pan, Jay

Publication type:

Article

Assessing Consumer Gains from a Drug Price Control Policy in the United States.

Published in:

Southern Economic Journal, 2006, v. 73, n. 1, p. 233, doi. 10.2307/20111885

By:

Santerre, Rexford E.;
Vernon, John A.

Publication type:

Article

Using Analytics to Gain Insights on U.S. Prescription Drug Prices: An Inductive Analysis.

Published in:

Journal of Public Policy & Marketing, 2021, v. 40, n. 4, p. 538, doi. 10.1177/0743915621993173

By:

Iacocca, Kathleen;
Vallen, Beth

Publication type:

Article

Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations.

Published in:

JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 216, doi. 10.1093/jnci/djad212

By:

Michaeli, Daniel Tobias;
Michaeli, Thomas;
Albers, Sebastian;
Michaeli, Julia Caroline

Publication type:

Article

Hyperactive drug price?

Published in:

Business & Society Review (00453609), 1993, n. 86, p. 78

By:

Moskowitz, Milton R.

Publication type:

Article

MEDICARE DRUG PRICE NEGOTIATIONS: A BLUEPRINT FOR ETHICAL PRICING ACROSS THE HEALTHCARE SYSTEM.

Published in:

FIU Law Review, 2025, v. 19, n. 1, p. 71, doi. 10.25148/lawrev.19.1.5

By:

Fox, Jacqueline R.

Publication type:

Article

Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit.

Published in:

Health Economics, Policy & Law, 2024, v. 19, n. 2, p. 216, doi. 10.1017/S1744133123000117

By:

Kleining, Katrin;
Laufenberg, Jan;
Thrun, Philip;
Ehlert, Dorothee;
Wasem, Jürgen;
Bartol, Arne

Publication type:

Article

The relationship between drug price and purity and population level harm.

Published in:

Trends & Issues in Crime & Criminal Justice, 2020, n. 598, p. 1

By:

Hughes, Caitlin;
Hulme, Shann;
Ritter, Alison

Publication type:

Article

The international drug price indicator guide: An objective source of information about medicine prices.

Published in:

Indian Journal of Pharmacology, 2014, v. 46, n. 6, p. 662, doi. 10.4103/0253-7613.144949

By:

Pathiyil Ravi Shankar

Publication type:

Article

Gang wars, gang employment and drug prices.

Published in:

Journal of Bioeconomics, 2019, v. 21, n. 1, p. 37, doi. 10.1007/s10818-018-09281-x

By:

Prinz, Aloys;
Ehrmann, Thomas

Publication type:

Article

Antifungal drug price increases in the United States, 2000–2019.

Published in:

Mycoses, 2022, v. 65, n. 9, p. 859, doi. 10.1111/myc.13486

By:

Thomas, Christine M.;
Shae, Whitney;
Koestler, Devin;
DeFor, Terese;
Bahr, Nathan C.;
Alpern, Jonathan D.

Publication type:

Article

Effects of drug purchasing under joint price caps policy in Fujian Province, China.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2020, v. 29, n. 2, p. 139, doi. 10.5246/jcps.2020.02.012

By:

Ruojing Zhou;
Bin Jiang

Publication type:

Article

Predicting the next round of drugs for Medicare price negotiation.

Published in:

Science Translational Medicine, 2024, v. 16, n. 776, p. 1, doi. 10.1126/scitranslmed.adq5711

By:

Vogel, Matthew;
Tellier, Adam;
Conti, Rena M.

Publication type:

Article

Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.

Published in:

2020

By:

Hernandez, Inmaculada;
San-Juan-Rodriguez, Alvaro;
Good, Chester B.;
Gellad, Walid F.

Publication type:

journal article

Lower drug prices can improve innovation.

Published in:

European Competition Journal, 2018, v. 14, n. 2/3, p. 278, doi. 10.1080/17441056.2018.1512231

By:

Canoy, Marcel;
Tichem, Jan

Publication type:

Article

The EpiPen Problem: Analyzing Unethical Drug Price Increases and the Need for Greater Government Regulation.

Published in:

University of Miami Business Law Review, 2017, v. 26, n. 1, p. 129

By:

Rashid, Talal

Publication type:

Article

Pharmacy Benefit Managers, Rebates, and Drug Prices: Conflicts of Interest in the Market for Prescription Drugs.

Published in:

Yale Law & Policy Review, 2020, v. 38, n. 2, p. 360

By:

Shepherd, Joanna

Publication type:

Article

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework.

Published in:

Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2019.1583536

By:

Moreno, Santiago G.;
Epstein, David

Publication type:

Article

A comparative study of orphan drug prices in Europe.

Published in:

Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1297886

By:

Young, Katherine Eve;
Soussi, Imen;
Hemels, Michiel;
Toumi, Mondher

Publication type:

Article

Prescription Drug Price Transparency.

Published in:: Benefits Quarterly, 2019, v. 35, n. 4, p. 68
Publication type:: Article